ESR2 and neoplasm: Quantitatively it was possible to identify ERα-positive, ERβ-positive tumours (38 out of 51, Figures 3A and 4A) as well as ERα-positive, ERβ-negative tumours (3 out of 51, Figure 3B compared with Figure 4B; 2 out of 51).